Model Number JF-260V |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Hemorrhage/Bleeding (1888); Perforation (2001); Pancreatitis (4481); Unspecified Hepatic or Biliary Problem (4493)
|
Event Date 06/03/2021 |
Event Type
Injury
|
Event Description
|
Olympus reviewed the following literature "success and safety of needle knife papillotomy and fistulotomy based on papillary anatomy: a prospective controlled trial." literature summary this study aimed to evaluate the validity and safety of this individualized therapy, the initial success rate of biliary cannulation (isrbc), and complication rates of patients who underwent nkp and nkf were compared prospectively among different types of mdps and between two precut approaches.A total of 188 out of 1674 patients undergoing ercp satisfied the criteria for early precutting: 75 patients were assigned to the nkp group and 113 to the nkf group.The total initial success rate of biliary cannulation (isrbc) of the precut techniques (both nkp and nkf) for patients with dbc was 91.5%.The isrbc of patients in the nkp group was similar to that of the nkf group (90.7% vs 92.0%, p>.05).The isrbc of the patients in the swollen mdp subgroup (96.1%) was higher than that of patients in the distorted mdp subgroup (81.8%, p=.030).The total and specific complications of the patients of the nkp group were similar to those of the nkf group (p>.05).This study concluded that nkp and nkf, as selected based on mdp anatomy, are equally safe and highly efficient for patients with dbc to allow biliary cannulation.Selecting a precut method based on mdp anatomy is an efective and safe strategy for patients with dbc.Type of adverse events/number of patients acute pancreatitis (11).Bleeding (4).Cholangitis (1).Perforation (1).Initial unsuccess of biliary cannulation (16).This article includes 2 reports: (b)(6) : jf-260v was selected to represent jf 260 documented in the article.(b)(6) : kd-10q-1 was selected to represent kd-10-1 documented in the article.This report is 1 of 2 for - (b)(6) : jf-260v was selected to represent jf 260 documented in the article.
|
|
Manufacturer Narrative
|
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
|
|
Manufacturer Narrative
|
This supplemental report is being submitted to provide additional information from the author and the legal manufacturer's investigation.The device history records (dhr) for this device could not be reviewed since the serial number was not provided.Olympus ships devices manufactured according to all applicable procedures and meet final product release criteria.A definitive root cause was not identified.Based on the available information, the legal manufacturer was unable to determine the probable cause of the adverse events since the device was not returned for evaluation.No malfunctions were reported.Olympus will continue to monitor field performance for this device.
|
|
Event Description
|
Additional information received from the author: the serial number is not available.No malfunctions occurred.The author reported the adverse events were attributed to the patient's underlying pathology and disease state and not the olympus device.
|
|
Search Alerts/Recalls
|